Buy or sell LunaDNA stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

LunaDNA Stock

The first and largest health and DNA research platform owned by its community.

About LunaDNA Stock

Created by co-founders of the $40B DNA sequencing leader Illumina, Luna DNA incentivizes the sharing of health and DNA data for research. LunaDNA rewards people for sharing the data they already own while contributing to medical research and discovery that saves lives. DNA sequencing data has become siloed. As personal DNA sequencing has risen in popularity, the data has become siloed as each company looks to maximize their individual profit from this data. There is currently little incentive for consumers to contribute their DNA and health information to a third party database. There are also multiple privacy, security, and trust issues that limit broad participation. The solution is LunaDNA. LunaDNA is a community owned database that rewards individuals shares in the database and rewards for contributing their health and DNA data. Shares entitle members to a share in the profits from medical research and discoveries. The proceeds flow back to the community like dividends as researchers pay to access the data for discovery.

Funding History

December 2017$2.0M
May 2018$2.0M

Management

Co-Founder and President

Dawn Barry

Co-Founder & CFO

David Lewis

CIO

Scott Kahn, PhD

VP Marketing

Aaron Mendes

Chief Architect

Kenneth Bloom

CEO & Co-Founder

Bob Kain

Vice President, Strategy and Business Operations

Debora Thompson

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from LunaDNA or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 110K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo